Blankenstein T - Search Results

1

The role of CD4 T cells in rejection of solid tumors.

Poncette L, Bluhm J, Blankenstein T. Poncette L, et al. Among authors: blankenstein t. Curr Opin Immunol. 2022 Feb;74:18-24. doi: 10.1016/j.coi.2021.09.005. Epub 2021 Oct 4. Curr Opin Immunol. 2022. PMID: 34619457 Free PMC article. Review.

2

Cytokines and cancer: experimental systems.

Blankenstein T, Rowley DA, Schreiber H. Blankenstein T, et al. Curr Opin Immunol. 1991 Oct;3(5):694-8. doi: 10.1016/0952-7915(91)90098-l. Curr Opin Immunol. 1991. PMID: 1755987 Review.

3

Lack of correlation between rejection of tumor cells co-expressing interleukin-2 and B7.1 and vaccine efficiency.

Cayeux S, Richter G, Becker C, Beck C, Aicher A, Pezzutto A, Dörken B, Blankenstein T. Cayeux S, et al. Among authors: blankenstein t. Eur J Immunol. 1997 Jul;27(7):1657-62. doi: 10.1002/eji.1830270710. Eur J Immunol. 1997. PMID: 9247574

4

B cells inhibit induction of T cell-dependent tumor immunity.

Qin Z, Richter G, Schüler T, Ibe S, Cao X, Blankenstein T. Qin Z, et al. Among authors: blankenstein t. Nat Med. 1998 May;4(5):627-30. doi: 10.1038/nm0598-627. Nat Med. 1998. PMID: 9585241

5

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

Qin Z, Blankenstein T. Qin Z, et al. Among authors: blankenstein t. Immunity. 2000 Jun;12(6):677-86. doi: 10.1016/s1074-7613(00)80218-6. Immunity. 2000. PMID: 10894167 Free article.

6

Tumor rejection by disturbing tumor stroma cell interactions.

Ibe S, Qin Z, Schüler T, Preiss S, Blankenstein T. Ibe S, et al. Among authors: blankenstein t. J Exp Med. 2001 Dec 3;194(11):1549-59. doi: 10.1084/jem.194.11.1549. J Exp Med. 2001. PMID: 11733570 Free PMC article.

7

Naive CD8(+) but not CD4(+) T cells induce maturation of dendritic cells.

Schüler T, Blankenstein T. Schüler T, et al. Among authors: blankenstein t. J Mol Med (Berl). 2002 Aug;80(8):533-41. doi: 10.1007/s00109-002-0360-4. Epub 2002 Jun 19. J Mol Med (Berl). 2002. PMID: 12185454

8

The role of IFN-gamma in tumor transplantation immunity and inhibition of chemical carcinogenesis.

Blankenstein T, Qin Z. Blankenstein T, et al. Curr Opin Immunol. 2003 Apr;15(2):148-54. doi: 10.1016/s0952-7915(03)00007-4. Curr Opin Immunol. 2003. PMID: 12633663 Review.

9

Cutting edge: CD8+ effector T cells reject tumors by direct antigen recognition but indirect action on host cells.

Schüler T, Blankenstein T. Schüler T, et al. Among authors: blankenstein t. J Immunol. 2003 May 1;170(9):4427-31. doi: 10.4049/jimmunol.170.9.4427. J Immunol. 2003. PMID: 12707316

10

The role of tumor stroma in the interaction between tumor and immune system.

Blankenstein T. Blankenstein T. Curr Opin Immunol. 2005 Apr;17(2):180-6. doi: 10.1016/j.coi.2005.01.008. Curr Opin Immunol. 2005. PMID: 15766679 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page